“…Other treatments that were mentioned in the articles as being potentially beneficial but that would not likely be available to, or practicable for, U.S. out-ofhospital personnel are not listed in the table. These include dexamethasone (81), methylscopolamine (91), metaproterenol (66,139), 4-aminopyridine (134), amrinone (96,138), angiotensin II (25), theophylline (139), enoxamine (73), and vasopressin (112). General supportive care measures (e.g., airway management measures, fluids, anticonvulsants, bicarbonate) might have been beneficial in some cases but were difficult to evaluate and are not specifically addressed in the table or this summary.…”